Status:
COMPLETED
Metal Ion Levels in Stryker Trident II Tritanium System with Modular Dual Mobility (MDM) Liner, Ceramic Head, and SecurFit Advanced Stems
Lead Sponsor:
Hospital for Special Surgery, New York
Collaborating Sponsors:
Stryker Nordic
Conditions:
Hip Pain
Eligibility:
All Genders
21-80 years
Phase:
NA
Brief Summary
Metal Ions levels of cobalt, chromium, and titanium in 40 patients preoperatively and at least 1 year status post total hip replacement with the Trident II Tritatnium system using an MDM liner and cer...
Eligibility Criteria
Inclusion
- Patients who will be undergoing a total hip replacement with a Stryker Trident II cup
- Patients have signed an Institutional Review Board (IRB) approved consent form
- Patient is 21-80
- Patient has a diagnosis of Non-Inflammatory Degenerative Joint Disease
- Patient is willing and able to comply with postoperative scheduled clinical evaluations.
Exclusion
- Patients who have not been consented as part of the Collaborative Orthopaedic Replacement Registry (CORRe) database
- Patients with other joint replacements (shoulder/knee)
- Patients with bilateral hip replacements
- Prisoners
- International Patients
Key Trial Info
Start Date :
February 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 11 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03433742
Start Date
February 22 2018
End Date
January 11 2024
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021